News and Trends 14 Dec 2022
NMD Pharma cleared for spinal muscular atrophy trial
NMD Pharma A/S has received clearance for its investigational new drug (IND) application from the US Food and Drug Administration (FDA) to advance NMD670 into a phase II clinical study…